MDM2 encodes an E3 ubiquitin ligase that is the primary regulator of p53 tumor suppressor protein. While classically studied in cancer, MDM2-p53 pathway plays complex roles in neuronal survival, DNA damage responses, and neurodegenerative diseases.
MDM2 (Mouse Double Minute 2 Homolog) is a key negative regulator of p53, the guardian of the genome. The MDM2-p53 axis is one of the most important pathways in cell biology, controlling cell cycle, apoptosis, and DNA repair. In neurons, this pathway has additional implications for neurodegeneration, as p53 has both pro-survival and pro-death functions depending on context.
| Property |
Value |
| Gene Symbol |
MDM2 |
| Full Name |
MDM2 Proto-Oncogene, E3 Ubiquitin Protein Ligase |
| Chromosomal Location |
12q15 |
| NCBI Gene ID |
4193 |
| OMIM ID |
164785 |
| Ensembl ID |
ENSG00000135679 |
| UniProt ID |
Q00978 |
| Encoded Protein |
MDM2 protein |
| Associated Diseases |
Li-Fraumeni syndrome, various cancers, Alzheimer's disease, Parkinson's disease |
MDM2 is a RING-finger E3 ubiquitin ligase with multiple functions:
- Catalyzes p53 ubiquitination and degradation
- Nuclear export of p53
- Inhibits p53 transcriptional activity
- Negative feedback loop: p53 activates MDM2 expression
- Ubiquitinates other targets: FOXO, NF-κB, p73
- Regulates DNA repair proteins
- Controls cell cycle progression
- May have E3 ligase-independent functions
- Responds to neuronal DNA damage
- Controls neuronal apoptosis
- Regulates synaptic plasticity
- May affect age-related neurodegeneration
- MDM2 expression is altered in AD brains
- p53-mediated apoptosis contributes to neuronal loss
- MDM2-p53 axis may be dysregulated
- Some MDM2 polymorphisms affect AD risk
- MDM2 protects against dopaminergic neuron death
- p53 can promote or inhibit PD pathology
- Mitochondrial dysfunction involves MDM2
- Therapeutic targeting is being explored
- MDM2 expression is altered in ALS
- Motor neuron survival involves p53 pathways
- DNA damage responses are impaired in ALS
MDM2 has widespread expression:
- Highest expression: Heart, brain, skeletal muscle
- Ubiquitous: Most tissues
- Cellular localization: Predominantly nuclear
In the brain:
- Expressed in neurons and glia
- Higher expression in cortex and hippocampus
- Regulated by neuronal activity
- Marine & Lozano, MDM2-mediated p53 degradation (2010)
- Oren, MDM2: the role in apoptosis and cancer (2003)
- Sliwinska et al., MDM2-p53 in neurodegeneration (2016)
- Tan et al., MDM2 in neuronal death and disease (2018)